Search is Powered by Google
Endocrinology News

Simultaneous Testing For Thyroid Hormones

Main Category: Endocrinology
Article Date: 22 Apr 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 and a half stars

4.5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Randox Laboratories produces Thyroid Array biochips to simultaneously test for three thyroid hormones in a single sample. Thyroid-stimulating hormone (TSH) is released by the pituitary gland in the brain.

Thyroxine (FT4 or TT4) and tri-iodothyronine (FT3 or TT3) are hormones produced by the thyroid gland. TSH is performed as the initial screening test and all three hormones are essential in the diagnosis of thyroid disease.

According to the UK National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: "Currently, measurement of the serum TSH concentration is the most reliable indicator of thyroid status at the tissue level."

Thyroid Array biochips simultaneously test for all three thyroid hormones in a single sample. The Evidence immunoassay analyser from Randox Laboratories offers the unique option of reflex reporting. If the TSH test result is within the normal range, only the TSH result is reported and the laboratory only pays for one test. If the TSH test result is elevated or low, the thyroxine and tri-iodothyronine test results are automatically reported as well. Reflex reporting offers a number of advantages: only one blood sample is required; the laboratory only performs one test procedure; and the laboratory only pays for the extra thyroid hormone tests when they are required.

The most common thyroid diseases are hyperthyroidism and hypothyroidism, affecting about 2% of the population. In hyperthyroidism, thyroid hormone levels are higher than normal; in hypothyroidism, thyroid hormone levels are low. Other thyroid conditions are goitre and thyroiditis. Thyroid cancer varies between slow-growing tumours with a good prognosis, to aggressive tumours with limited treatment options. Thyroid problems are about ten times more common in women than in men.

About Randox

Randox is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; environmental diagnostics; recombinant proteins and antibodies.

For further information contact:

Randox Laboratories
Diamond Road
Crumlin
Co. Antrim BT29 4QY
United Kingdom
Tel: +44 (0) 28 9442 2413
Fax: +44 (0) 28 9445 2912
marketing@randox.com
http://www.randox.com





Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Treating Pituitary Tumors image Treating Pituitary Tumors

Tumors in the pituitary can release hormones that wreak havoc throughout the body. Listen to experts explain why shrinking tumors is an important goal in treating symptoms of acromegaly...

Acromegaly image Acromegaly

Being tall is a physical trait that's often valued in our society, whether it's on fashion runways or basketball courts. But for people with acromegaly, excessive growth is a symptom of a serious condition...

View more videos...

Add Your Advertisement Here